Kingtech Bio Chem Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.40 Cr
as on 05-07-2024
- Paid Up Capital ₹ 2.40 Cr
as on 05-07-2024
- Company Age 11 YEARS, 1 MONTH
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.98 Cr
as on 05-07-2024
- Satisfied Charges ₹ 19.94 Cr
as on 05-07-2024
- Revenue 14.13%
FY 2023
- Profit -9.60%
FY 2023
- Ebitda -1.16%
FY 2023
- Net Worth 5.91%
FY 2023
- Total Assets 4.49%
FY 2023
About Kingtech Bio Chem
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹9.98 Cr. The company has closed loans amounting to ₹19.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Darshan Barot, Ankur Singhal, and Suman Lata serve as directors at the Company.
- CIN/LLPIN
U24233GJ2013PTC076294
- Company No.
076294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kingtech Bio Chem Private Limited offer?
Kingtech Bio Chem Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Acaricide, Termiticide, Fungicides, Selective Herbicide, Insecticides.
Who are the key members and board of directors at Kingtech Bio Chem?
Board Members(3)
Financial Performance and Corporate Structure Insights of Kingtech Bio Chem.
Kingtech Bio Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.13% increase. The company also saw a slight decrease in profitability, with a 9.6% decrease in profit. The company's net worth moved up by a moderate rise of 5.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kingtech Bio Chem?
In 2023, Kingtech Bio Chem had a promoter holding of 56.19% and a public holding of 43.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 20 Oct 2023 | ₹0.94 M | Open |
Indian Bank Creation Date: 14 Nov 2022 | ₹9.89 Cr | Open |
Others Creation Date: 27 Oct 2020 | ₹8.20 Cr | Satisfied |
How Many Employees Work at Kingtech Bio Chem?
Kingtech Bio Chem has a workforce of 61 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 31, 2022, Kingtech Bio Chem has raised a total of ₹ 4.42 Cr, with the most recent deal valued at ₹ 3.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
